2024
380 WHAT TREATMENT WOULD PATIENTS WITH ACL INJURY CONSIDER TO PREVENT POST-TRAUMATIC OSTEOARTHRITIS?
Kennedy K, Waddell L, Easterbrook A, Katz J, Jacobs C, Jones M, Selzer F, Losina E, Fraenkel L, Bansback N. 380 WHAT TREATMENT WOULD PATIENTS WITH ACL INJURY CONSIDER TO PREVENT POST-TRAUMATIC OSTEOARTHRITIS? Osteoarthritis And Cartilage 2024, 32: s272. DOI: 10.1016/j.joca.2024.02.392.Peer-Reviewed Original ResearchAn Emergency Department-based system intervention to improve osteoporosis screening for older adults at high-risk of fracture
Jackson L, Skains R, Mudano A, Techarukpong N, Booth J, Saag K, Fraenkel L, Danila M. An Emergency Department-based system intervention to improve osteoporosis screening for older adults at high-risk of fracture. JBMR Plus 2024, 8: ziae038. PMID: 38681999, PMCID: PMC11055962, DOI: 10.1093/jbmrpl/ziae038.Peer-Reviewed Original ResearchElectronic medical record alertsBone mineral density testingElectronic medical recordsOsteoporosis careEmergency departmentED visitsOlder adultsOsteoporosis screeningLong-term care residentsTertiary-care emergency departmentImprove osteoporosis screeningBone mineral densityFracture riskHigh risk of fractureHigh riskScreening educationCare deliveryFall riskCare residentsChief complaintTest referralsAbstract FallsStudy staffBMD testingParticipant refusalPreferences and decisional considerations relating to opioid agonist therapy among Ukrainian people who use drugs: A conjoint analysis survey.
Bromberg D, Madden L, Fraenkel L, Muthulingam D, Rhoades D, Dvoriak S, Dumchev K, Pykalo I, Altice F. Preferences and decisional considerations relating to opioid agonist therapy among Ukrainian people who use drugs: A conjoint analysis survey. PLOS Global Public Health 2024, 4: e0002725. PMID: 38277422, PMCID: PMC10817130, DOI: 10.1371/journal.pgph.0002725.Peer-Reviewed Original ResearchOpioid agonist therapyWithdrawal symptomsAdverse side effectsAgonist therapySide effectsOpioid use disorderQuality-of-life improvementUse disorderCombined HIVHIV incidenceClinical decision-makingDosing frequencyRespondent-driven samplingOpioidOpioid epidemicAssess preferencesClinical concernPatient preferencesPatientsDelivery strategiesTherapyDisordersHIVPatient concernsWithdrawalThe Art of Communicating Risk and Benefit to Promote Shared Decision‐Making, Informed by Behavioral Economic Principles
Curtis J, Fraenkel L. The Art of Communicating Risk and Benefit to Promote Shared Decision‐Making, Informed by Behavioral Economic Principles. Arthritis & Rheumatology 2024, 76: 493-496. PMID: 37909387, DOI: 10.1002/art.42742.Peer-Reviewed Original Research
2023
Mortality Rate Among Patients with Alcohol Use Disorder with Two or More Readmissions to the Hospital
Terechin O, Johansen P, Rosen A, Morgan M, Fraenkel L. Mortality Rate Among Patients with Alcohol Use Disorder with Two or More Readmissions to the Hospital. Journal Of Community Hospital Internal Medicine Perspectives 2023, 13: 90-93. PMID: 37868665, PMCID: PMC10589033, DOI: 10.55729/2000-9666.1235.Peer-Reviewed Original ResearchAlcohol use disorderMore hospital readmissionsHigh mortality rateUse disordersMortality rateHospital readmissionPsychiatric careUtilization of medicationsHazardous alcohol consumptionSerious medical conditionMore readmissionsChart reviewMost patientsDeceased patientsHigh morbidityClinical dataSurvival statusMedical conditionsPatientsAlcohol consumptionSignificant burdenPsychiatric conditionsReadmissionDisordersMedications
2018
Characteristics of Surrogate Decision Makers Selecting Life-sustaining Therapy for Severe Intracerebral Hemorrhage Patients: a Neuropalliative Care Survey of the US Population (S7.003)
Hwang D, Knies A, White D, Holloway R, Sheth K, Fraenkel L. Characteristics of Surrogate Decision Makers Selecting Life-sustaining Therapy for Severe Intracerebral Hemorrhage Patients: a Neuropalliative Care Survey of the US Population (S7.003). Neurology 2018, 90 DOI: 10.1212/wnl.90.15_supplement.s7.003.Peer-Reviewed Original Research
2017
Priorities of surrogate decision makers when making decisions for intracerebral hemorrhage patients with poor prognosis: a latent class analysis of the US population (P3.033)
Hwang D, Knies A, Holloway R, White D, Sheth K, Fraenkel L. Priorities of surrogate decision makers when making decisions for intracerebral hemorrhage patients with poor prognosis: a latent class analysis of the US population (P3.033). Neurology 2017, 88 DOI: 10.1212/wnl.88.16_supplement.p3.033.Peer-Reviewed Original Research
2012
A Pilot Randomized Controlled Trial of a Decision Support Tool to Improve the Quality of Communication and Decision‐Making in Individuals with Atrial Fibrillation
Fraenkel L, Street RL, Towle V, O'Leary JR, Iannone L, Van Ness P, Fried TR. A Pilot Randomized Controlled Trial of a Decision Support Tool to Improve the Quality of Communication and Decision‐Making in Individuals with Atrial Fibrillation. Journal Of The American Geriatrics Society 2012, 60: 1434-1441. PMID: 22861171, PMCID: PMC3419306, DOI: 10.1111/j.1532-5415.2012.04080.x.Peer-Reviewed Original ResearchConceptsNonvalvular atrial fibrillationIntervention participantsAtrial fibrillationControl groupTreatment planPrimary care clinicsCurrent treatment planPatient-clinician communicationPhysician-patient communicationDecisional Conflict ScaleSecondary outcomesPrimary outcomeStroke riskCare clinicsControlled TrialsIntervention groupSide effectsValues clarityMedicationsFibrillationStrokeLower scoresRiskTrialsVisitsDecision tool to improve the quality of care in rheumatoid arthritis
Fraenkel L, Peters E, Charpentier P, Olsen B, Errante L, Schoen RT, Reyna V. Decision tool to improve the quality of care in rheumatoid arthritis. Arthritis Care & Research 2012, 64: 977-985. PMID: 22392766, PMCID: PMC3375390, DOI: 10.1002/acr.21657.Peer-Reviewed Original ResearchConceptsRheumatoid arthritisBiologic therapyDisease-modifying antirheumatic drugsOngoing active diseaseProportion of subjectsQuality of careActive diseaseAntirheumatic drugsRA patientsClinical trialsPatients' willingnessClinical practiceClarity of valuesValues clarityBiologicsArthritisPatientsTherapyPreliminary evidencePerceived knowledgeCareEfficacyRiskSubjectsDisease
2010
Informing Patients
Peters E, Hart PS, Fraenkel L. Informing Patients. Medical Decision Making 2010, 31: 432-436. PMID: 21191122, DOI: 10.1177/0272989x10391672.Peer-Reviewed Original ResearchAdolescentAdultAgedAnalysis of VarianceComprehensionData CollectionDrug-Related Side Effects and Adverse ReactionsFemaleHealth EducationHealth Knowledge, Attitudes, PracticeHealth LiteracyHumansInternetMaleMathematical ConceptsMiddle AgedPatient Education as TopicPerceptionPrescription DrugsRiskRisk AssessmentYoung Adult
2009
Racial Disparities in Treatment Preferences for Rheumatoid Arthritis
Constantinescu F, Goucher S, Weinstein A, Fraenkel L. Racial Disparities in Treatment Preferences for Rheumatoid Arthritis. Medical Care 2009, 47: 350-355. PMID: 19165120, PMCID: PMC3682220, DOI: 10.1097/mlr.0b013e31818af829.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overAntirheumatic AgentsArthritis, RheumatoidBlack or African AmericanCommunicationDecision MakingDistrict of ColumbiaFemaleHealth Knowledge, Attitudes, PracticeHealthcare DisparitiesHumansInterviews as TopicMaleMedication AdherenceMethotrexateMiddle AgedOutpatient Clinics, HospitalPatient SatisfactionPsychometricsRheumatologySocioeconomic FactorsSoftwareTumor Necrosis Factor-alphaVirginiaWhite PeopleYoung AdultConceptsAggressive therapyRheumatoid arthritisTreatment preferencesAggressive treatmentChronic diseasesRacial disparitiesConsecutive eligible patientsLong-term outcomesAvailable treatment optionsBest available treatment optionsImportant clinical implicationsSimilar disease severityEligible patientsWhite patientsBlack patientsTreatment optionsUnadjusted analysesPatient preferencesPhysician communicationPatient educationPatientsDisease severityMedical interventionsClinical implicationsTherapy